What's in Journey Medical Corporation's pipeline?

Journey Medical Corporation has 11 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 9 in Phase 2, 0 in Phase 1.

Which companies overlap with Journey Medical Corporation's portfolio?

Top competitors by shared drug class: AbbVie, Aclaris Therapeutics, Inc., Ain Shams University, Astellas Pharma Inc, Boehringer Ingelheim.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/journey-medical-corporation.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Journey Medical Corporation — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Journey Medical Corporation pipeline: 0 marketed, 0 filed, 2 Phase 3, 9 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 9 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
DFD-29	DFD-29	phase 3	Topical antimicrobial		Dermatology
glycopyrronium Topical Wipes	glycopyrronium Topical Wipes	phase 3	Anticholinergic agent / Antiperspirant	Muscarinic M3 receptor	Dermatology

Therapeutic area mix

Dermatology · 2
Ophthalmology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AbbVie · 1 shared drug class
Aclaris Therapeutics, Inc. · 1 shared drug class
Ain Shams University · 1 shared drug class
Astellas Pharma Inc · 1 shared drug class
Boehringer Ingelheim · 1 shared drug class
Covis · 1 shared drug class
Forest Labs Inc · 1 shared drug class
· 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Journey Medical Corporation:

Cite this brief

Drug Landscape (2026). Journey Medical Corporation — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/journey-medical-corporation. Accessed 2026-05-17.